Producing flu vaccines will be faster and cheaper, thanks to MSU technology

East lansing, Mich. -- Technology from Michigan State animal science labs looks to produce new human flu vaccines quicker and cheaper than current methods.

While studying new techniques to produce vaccines for Marek's disease, a common chicken disease that causes big losses for poultry producers, Paul Coussens, MSU professor of animal science and microbiology and molecular genetics, and his colleagues found a cell line that had intriguing potential for growing flu virus a change from the fertilized chicken eggs that are now used to grow the virus strains for vaccines.

HepaLife Technologies Inc., a biotechnology company based in Vancouver, has licensed the technology from MSU and plans to produce cell culture-based flu vaccine.

"We want to proceed as quickly as possible," said Harmel Rayat, president of HepaLife. "There's no time to waste. Sooner or later the avian flu virus will be in North America. It's not if, it's when."

"The recent highly virulent avian flu cases in Asia and fears about a pandemic have highlighted the problems with traditional influenza vaccine production methods, particularly the length of time to produce a new vaccine and the amount of vaccine that can be produced on short notice," said Coussens, who also is the director of the MSU Center for Animal Functional Genomics.

Building on work done by graduate student Amin Abujoub and assistant professor David Reilly, Coussens and his collaborators found the cell line would grow almost every type of flu virus: avian, swine, equine and human. In cell culture-based vaccine production, scientists infect cells with flu strains. Then they grow the virus in large vats or bioreactors. The virus is killed and purified to make the vaccine.

Growing virus in cell culture could dramatically speed up vaccine production. For the past 50 years, flu vaccines have been made by injecting 11-day-old fertilized chicken eggs with a flu virus strain. The vir

Contact: Sue Nichols
Michigan State University

Page: 1 2

Related biology news :

1. Producing medicines in plant seeds
2. Producing bio-ethanol from agricultural waste a step closer
3. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
4. Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?
5. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
6. Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks
7. Painkillers may threaten power of vaccines
8. Interdisciplinary grant to Yale: Creating nanodevices for delivery of vaccines
9. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
10. Handling HPV vaccines and screening: The views of 100 authors
11. Promising preclinical results with live attenuated H5N1 vaccines

Post Your Comments:

(Date:12/18/2019)... ... December 17, 2019 , ... Mitotech S.A, a Luxembourg-based clinical-stage ... its U.S. Phase 3 study VISTA-2 building on positive results of VISTA-1 clinical ... to severe Dry Eye Disease (DED). SkQ1 belongs to the class of cardiolipin ...
(Date:12/18/2019)... SEATTLE (PRWEB) , ... December 18, 2019 , ... ... higher education planning, has announced the Top 10 Master's in Biotechnology Degree Programs ... accredited colleges and universities in the nation. Each program is evaluated based on ...
(Date:12/14/2019)... ... 12, 2019 , ... Crop Enhancement Inc., an ... Jean Pougnier as chief business officer. Mr. Pougnier will lead the company’s efforts ... will position the company for maximum commercial success. As part of the expansion ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... ... a Digital World at The Fletcher School at Tufts University, is pleased to ... Foundation. The grant will be administered by Tufts University, and will help to ...
(Date:12/31/2019)... ... December 31, 2019 , ... Vici ... development lab in Maryland. Emphasis will be in expanding capabilities in ... Vici Health Sciences will be well positioned to meet the growing demand for ...
(Date:12/27/2019)... HARBOR TOWNSHIP, N.J. (PRWEB) , ... December 27, ... ... manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical ... first calendar year under new management . Following acquisition by CLJ Holdings ...
(Date:12/18/2019)... ... December 17, 2019 , ... Innovative Health, Inc. ... Electrophysiology (EP) devices since the company’s inception in 2016. This marks a record ... Johnson & Johnson company) have received 2 and 4 EP device clearances, respectively, ...
Breaking Biology Technology:
Cached News: